HR 3616
118th Congress
House
Transportation and Public Works
Aviation and airports
Drug therapy
Drug, alcohol, tobacco use
Emergency medical services and trauma care
Health technology, devices, supplies
Transportation employees
To direct the Administrator of the Federal Aviation Administration to include medications and medical equipment for the emergency treatment of known or suspected opioid overdose in aircraft emergency medical kits, and for other purposes.
Introduced: May 23, 2023
See on congress.gov
Everywhere this bill has been
3 steps
Introduced
In committee
Reported out
Passed House
Passed Senate
To President
Became law
May 24, 2023
Referred to the Subcommittee on Aviation.
May 23, 2023
Referred to the House Committee on Transportation and Infrastructure.
May 23, 2023
Introduced in House
Plain-English summary
This bill directs the Federal Aviation Administration (FAA) to require that medications and medical equipment for the emergency treatment of a known or suspected opioid overdose be included in an aircraft emergency medical kit; the FAA must, to the maximum extent possible, follow the guidance of the Aerospace Medical Association.
In a 2019 guidance document to the FAA, the Aerospace Medical Association recommended including an opioid antagonist (e.g., naloxone or Narcan) in an aircraft emergency medical kit.
What's happening now
Referred to the Subcommittee on Aviation.
Committees of jurisdiction
2